Cystic fibrosis drug study halted early
NCT ID NCT04375514
First seen Jan 04, 2026 · Last updated May 06, 2026 · Updated 27 times
Summary
This study tested an experimental drug called ARO-ENaC in healthy volunteers and people with cystic fibrosis. The goal was to see if it is safe and helps lung function. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS, PULMONARY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Nedlands, Washington, 6009, Australia
-
Research Site 2
Hamilton, 3204, Australia
-
Research Site 3
Chermside, Queensland, 4032, Australia
-
Research Site 4
South Brisbane, Queensland, 4101, Australia
-
Research Site 6
Grafton, Auckland, 1010, New Zealand
-
Research Site 7
Dunedin, 9054, New Zealand
-
Research Site 8
Christchurch, 8140, New Zealand
Conditions
Explore the condition pages connected to this study.